Every recall we track for Fagron, Inc — 22 in all — plus the complaints and injury reports the public filed about them.
Fagron recalls 6482 units/mg NYSTATIN 150 MU bulk powder due to label error on declared strength. This affects prescription compounding. No action needed as it's a labeling issue, not a safety hazard.
Fagron recalls NYSTATIN 2 BU bulk powder due to incorrect label strength. This affects prescription compounding products with specific NDC and lot numbers. Consumers should contact the manufacturer for details.
Fagron recalls 500 MU NYSTATIN bulk powder due to incorrect label strength. This affects prescription compounding. No action needed as it's a labeling error, not a safety hazard.
Fagron recalls 6482 units/mg NYSTATIN 5BU bulk powder due to incorrect label strength. This affects prescription compounding. No action needed as it's a labeling error, not a safety hazard.
Fagron recalls 1 kg Nandrolone Decanoate (Rx only) due to subpotent drug risk. This affects prescription compounding products with specific NDC and lot numbers.
Fagron recalls cherry-flavored SyrSpend SF Suspending Base in 500mL and 4L bottles due to Burkholderia gladioli contamination. This non-sterile product poses a microbial risk. Consumers should contact Fagron for details.
Fagron recalls 500g Nandrolone Decanoate for prescription compounding due to subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for return instructions.
Fagron recalls Nandrolone Decanoate 100g plastic containers for prescription compounding due to subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy.
Fagron recalls Nandrolone Decanoate 500g plastic containers for prescription compounding due to subpotent drug risk. Affected units have specific NDC and lot numbers.
Fagron recalls specific lots of Nandrolone Decanoate for prescription compounding due to subpotent drug quality. Affected products may not contain enough active ingredient for intended use.
